vs

Side-by-side financial comparison of FUELCELL ENERGY INC (FCEL) and RECURSION PHARMACEUTICALS, INC. (RXRX). Click either name above to swap in a different company.

FUELCELL ENERGY INC is the larger business by last-quarter revenue ($55.0M vs $35.5M, roughly 1.5× RECURSION PHARMACEUTICALS, INC.). FUELCELL ENERGY INC runs the higher net margin — -54.3% vs -304.2%, a 250.0% gap on every dollar of revenue. On growth, RECURSION PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (681.7% vs 11.5%). FUELCELL ENERGY INC produced more free cash flow last quarter ($-23.9M vs $-47.3M). Over the past eight quarters, FUELCELL ENERGY INC's revenue compounded faster (81.6% CAGR vs 60.5%).

FuelCell Energy, Inc. is a publicly traded fuel cell company headquartered in Danbury, Connecticut. It designs, manufactures, operates and services power plants based on molten carbonate fuel cells.

Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines artificial intelligence and large-scale high-throughput biological experimentation to discover and develop innovative therapies for rare diseases, oncology, inflammatory disorders, and other areas of unmet medical need. It primarily operates in North America and partners with global biopharmaceutical firms to advance its robust therapeutic pipeline.

FCEL vs RXRX — Head-to-Head

Bigger by revenue
FCEL
FCEL
1.5× larger
FCEL
$55.0M
$35.5M
RXRX
Growing faster (revenue YoY)
RXRX
RXRX
+670.2% gap
RXRX
681.7%
11.5%
FCEL
Higher net margin
FCEL
FCEL
250.0% more per $
FCEL
-54.3%
-304.2%
RXRX
More free cash flow
FCEL
FCEL
$23.4M more FCF
FCEL
$-23.9M
$-47.3M
RXRX
Faster 2-yr revenue CAGR
FCEL
FCEL
Annualised
FCEL
81.6%
60.5%
RXRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FCEL
FCEL
RXRX
RXRX
Revenue
$55.0M
$35.5M
Net Profit
$-29.9M
$-108.1M
Gross Margin
-12.1%
59.8%
Operating Margin
-51.5%
-304.8%
Net Margin
-54.3%
-304.2%
Revenue YoY
11.5%
681.7%
Net Profit YoY
27.9%
39.6%
EPS (diluted)
$-0.43
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FCEL
FCEL
RXRX
RXRX
Q4 25
$55.0M
$35.5M
Q3 25
$46.7M
$5.2M
Q2 25
$37.4M
$19.2M
Q1 25
$19.0M
$14.7M
Q4 24
$49.3M
$4.5M
Q3 24
$23.7M
$26.1M
Q2 24
$22.4M
$14.4M
Q1 24
$16.7M
$13.8M
Net Profit
FCEL
FCEL
RXRX
RXRX
Q4 25
$-29.9M
$-108.1M
Q3 25
$-91.7M
$-162.3M
Q2 25
$-38.0M
$-171.9M
Q1 25
$-28.3M
$-202.5M
Q4 24
$-41.4M
$-178.9M
Q3 24
$-32.7M
$-95.8M
Q2 24
$-32.1M
$-97.5M
Q1 24
$-19.8M
$-91.4M
Gross Margin
FCEL
FCEL
RXRX
RXRX
Q4 25
-12.1%
59.8%
Q3 25
-11.0%
-183.8%
Q2 25
-25.2%
-4.9%
Q1 25
-27.4%
-48.0%
Q4 24
-22.1%
-181.4%
Q3 24
-26.2%
53.7%
Q2 24
-31.6%
36.2%
Q1 24
-70.2%
19.1%
Operating Margin
FCEL
FCEL
RXRX
RXRX
Q4 25
-51.5%
-304.8%
Q3 25
-204.0%
-3327.6%
Q2 25
-95.7%
-916.8%
Q1 25
-172.9%
-1297.9%
Q4 24
-83.2%
-4042.4%
Q3 24
-141.9%
-377.1%
Q2 24
-184.5%
-697.4%
Q1 24
-254.5%
-698.4%
Net Margin
FCEL
FCEL
RXRX
RXRX
Q4 25
-54.3%
-304.2%
Q3 25
-196.1%
-3135.3%
Q2 25
-101.7%
-894.2%
Q1 25
-149.1%
-1373.3%
Q4 24
-84.0%
-3935.5%
Q3 24
-137.8%
-367.5%
Q2 24
-143.4%
-676.6%
Q1 24
-118.6%
-662.4%
EPS (diluted)
FCEL
FCEL
RXRX
RXRX
Q4 25
$-0.43
$-0.17
Q3 25
$-3.78
$-0.36
Q2 25
$-1.79
$-0.41
Q1 25
$-1.42
$-0.50
Q4 24
$-2.29
$-0.56
Q3 24
$-1.99
$-0.34
Q2 24
$-2.18
$-0.40
Q1 24
$-1.37
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FCEL
FCEL
RXRX
RXRX
Cash + ST InvestmentsLiquidity on hand
$278.1M
$743.3M
Total DebtLower is stronger
$103.8M
$9.6M
Stockholders' EquityBook value
$662.2M
$1.1B
Total Assets
$932.1M
$1.5B
Debt / EquityLower = less leverage
0.16×
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FCEL
FCEL
RXRX
RXRX
Q4 25
$278.1M
$743.3M
Q3 25
$174.7M
$659.8M
Q2 25
$177.0M
$525.1M
Q1 25
$208.4M
$500.5M
Q4 24
$257.3M
$594.4M
Q3 24
$267.2M
$427.6M
Q2 24
$260.1M
$474.3M
Q1 24
$297.5M
$296.3M
Total Debt
FCEL
FCEL
RXRX
RXRX
Q4 25
$103.8M
$9.6M
Q3 25
$106.4M
$11.9M
Q2 25
$109.4M
$14.2M
Q1 25
$112.3M
$16.4M
Q4 24
$115.7M
$19.0M
Q3 24
$112.7M
$20.5M
Q2 24
$116.2M
$22.9M
Q1 24
$107.2M
Stockholders' Equity
FCEL
FCEL
RXRX
RXRX
Q4 25
$662.2M
$1.1B
Q3 25
$556.2M
$1.0B
Q2 25
$609.2M
$919.1M
Q1 25
$635.2M
$933.9M
Q4 24
$656.9M
$1.0B
Q3 24
$675.8M
$524.6M
Q2 24
$639.8M
$584.4M
Q1 24
$663.9M
$401.2M
Total Assets
FCEL
FCEL
RXRX
RXRX
Q4 25
$932.1M
$1.5B
Q3 25
$830.5M
$1.4B
Q2 25
$883.8M
$1.3B
Q1 25
$907.5M
$1.3B
Q4 24
$944.1M
$1.4B
Q3 24
$948.9M
$726.5M
Q2 24
$916.8M
$775.9M
Q1 24
$923.2M
$557.8M
Debt / Equity
FCEL
FCEL
RXRX
RXRX
Q4 25
0.16×
0.01×
Q3 25
0.19×
0.01×
Q2 25
0.18×
0.02×
Q1 25
0.18×
0.02×
Q4 24
0.18×
0.02×
Q3 24
0.17×
0.04×
Q2 24
0.18×
0.04×
Q1 24
0.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FCEL
FCEL
RXRX
RXRX
Operating Cash FlowLast quarter
$-22.9M
$-46.1M
Free Cash FlowOCF − Capex
$-23.9M
$-47.3M
FCF MarginFCF / Revenue
-43.4%
-133.1%
Capex IntensityCapex / Revenue
1.8%
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-143.9M
$-378.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FCEL
FCEL
RXRX
RXRX
Q4 25
$-22.9M
$-46.1M
Q3 25
$-26.8M
$-117.4M
Q2 25
$-29.9M
$-76.4M
Q1 25
$-45.7M
$-132.0M
Q4 24
$5.8M
$-115.4M
Q3 24
$-63.4M
$-59.2M
Q2 24
$-37.1M
$-82.2M
Q1 24
$-58.3M
$-102.3M
Free Cash Flow
FCEL
FCEL
RXRX
RXRX
Q4 25
$-23.9M
$-47.3M
Q3 25
$-32.1M
$-117.6M
Q2 25
$-35.2M
$-79.6M
Q1 25
$-52.8M
$-133.8M
Q4 24
$-4.7M
$-116.7M
Q3 24
$-76.8M
$-63.8M
Q2 24
$-50.3M
$-83.4M
Q1 24
$-68.8M
$-109.0M
FCF Margin
FCEL
FCEL
RXRX
RXRX
Q4 25
-43.4%
-133.1%
Q3 25
-68.6%
-2272.5%
Q2 25
-94.0%
-413.9%
Q1 25
-277.8%
-907.4%
Q4 24
-9.5%
-2567.7%
Q3 24
-324.0%
-244.6%
Q2 24
-224.5%
-578.5%
Q1 24
-412.4%
-789.9%
Capex Intensity
FCEL
FCEL
RXRX
RXRX
Q4 25
1.8%
3.5%
Q3 25
11.2%
4.7%
Q2 25
14.1%
16.4%
Q1 25
37.2%
12.4%
Q4 24
21.4%
28.6%
Q3 24
56.6%
17.5%
Q2 24
58.9%
8.2%
Q1 24
63.3%
48.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FCEL
FCEL

Other$30.0M55%
Electricity Generation$12.2M22%
Services$7.3M13%
Advanced Technologies$5.5M10%

RXRX
RXRX

Segment breakdown not available.

Related Comparisons